A whole new mushroom convoy pulls up to Parliament!
Editorial, News, PolicyWhat’s happening at the Canadian Capital?
Canadian non-profit organization TheraPsil is leading a delegation of patients, advocates & experts to return to Ottawa this February from the 11th-17th seeking compassionate access to psilocybin…
Explore MycoMeditations Psilocybin-assisted Retreats
Business, EditorialMycoMeditations sets the bar for cutting edge psilocybin-assisted psychedelic retreat centers
Can Wearable Technology Help Alleviate Stress?
Business, Editorial, ResearchCan wearable technology help alleviate stress? Apollo Neuro's new wearable shows amazing promise
5 Next-Generation Psychedelics Entering Clinical Trials This Year
Editorial, ResearchModernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.
CATALYST Summit: 3 Psychedelic Speakers to Catch This Weekend
Culture, EditorialEven if you can't be there in person, it's not too late to get a discounted pass to tune in online.
Comparing MindMed, Atai Life Sciences, Compass Pathways: A Psychedelic Stock Analysis
Business, Editorial, NewsOur resident psychedelic investor explains a handful of important metrics to study when analyzing and comparing psychedelic stocks.
Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors
Business, EditorialPsychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.
Understanding 3 Risks of Investing in Psychedelic Stocks
Business, EditorialNo one is responsible for your financial future, other than yourself, so be responsible with your money.
Is Small Pharma a Good Psychedelic Stock Investment?
Business, EditorialOur resident Psychedelic Investor James Hallifax looks at the pros and cons of this Canadian-based company developing DMT for therapeutic use.
My Favorite Psychedelic Stocks: Part 1
Business, EditorialOur resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.